Mass Tort Talks featuring Susan Barfield
https://youtu.be/FmwfBTU4jXw Presented by The Mass Tort Institute Hi, my name is Susan and I am the founder and CEO of Case Works. My goal today …
COVID-19’s Impact on the Mass Tort Landscape
COVID-19’s Impact on the Mass Tort Landscape The mass tort landscape is reaching a new peak while COVID-19 outbreaks and the Delta variant continue to …
The Biggest Challenges for Mass Tort Firms
Mass tort litigation firms stand to recover large settlement amounts for their clients in mass tort litigation proceedings.
Advantages of Outsourcing Client Case Management
Whether you need to outsource core functions, simple business functions, or just looking for cost savings, outsourcing business processes and operations can benefit all types of law firms.
Zantac Litigation Update: Latest Developments
The mass action litigation against the makers of the popular antacid medication Zantac is still in the early stages. On April 1, 2020, the U.S. Food and Drug Administration (FDA) issued an immediate market withdrawal request of all ranitidine-based medications including Zantac.
PFAS Victims Reach Two Major Settlement Deals
DuPont and several related companies have committed $4 billion to cover liabilities stemming from their past use of toxic “forever chemicals” such as PFAS and PFOA. The group of companies also agreed to pay $83 million to settle multidistrict litigation in Ohio to compensate victims harmed by the chemicals.
$8.3 Billion Purdue Opioid Settlement Update
In mid-November 2020, the U.S. Bankruptcy Court for the Southern District of New York approved a federal settlement agreement valued at $8.3 billion between Purdue Pharma and the Department of Justice (DOJ). As part of the deal, Purdue will plead guilty to 3 felony criminal counts of defrauding the United States.
Judge Dismisses Zantac Claims on Federal Preemption
In two recent rulings, U.S. District Court Judge Robin L Rosenberg dismissed a host of claims against Zantac defendants based on federal pre-emption. In short, preemption is a doctrine that can shield drug manufacturers from liability in certain cases where they follow the FDA requirements for an approved drug or medication.
New MDL Formed for Elmiron Litigation
At its last meeting of 2020, the Judicial Panel on Multidistrict Litigation (JPML) decided to create a new Multidistrict Litigation (MDL) to hear claims filed …
Allergan’s Game of Hide & Seek with the FDA
According to complaints filed by plaintiff’s attorneys, Allergan’s misconduct includes using a loophole in the FDAs reporting requirements to hide instances of serious injuries associated …
ParaGard MDL Created in Northern District of Georgia
In a much-anticipated decision, the Judicial Panel on Multidistrict Litigation (JPML) ruled on December 16, 2020 to centralize ParaGard IUD claims against Teva Pharmaceuticals in …
Latest Defendant Shenanigans in the Valsartan Litigation
Plaintiffs injured by contaminated valsartan are fighting attempts by Walgreens, CVS and Rite Aid to avoid claims they misrepresented a generic high blood pressure drug …
Court Rules Against “Lifesaving Device” Claims for Hernia Mesh
In a recent court ruling C.R. Bard was told they cannot argue their hernia mesh implant is a “lifesaving device” in the upcoming bellwether trial …
Bayer’s Essure Defense Strategy to Avoid Liability
Two years after Bayer A.G. halted sales of Essure in the United States, the company announced it would settle outstanding legal claims for $1.6 billion. …
Truvada Generics Hit the Market
After years of raking in billions of dollars from its Tenofovir Disoproxil Fumarate (TDF) drug monopoly, Gilead Sciences will have to face competition from the …
J&J Loses Bid to Appeal $2.1 Billion Talc Powder Verdict
Last week, the Missouri Supreme Court shot down Johnson & Johnson’s bid to appeal a $2.1 billion jury verdict in favor of women who blamed …
FDA Recalls Metformin After Finding Known Carcinogen
The FDA continues to recommend manufacturer recalls of the popular diabetes medication metformin after testing shows the presence of a known carcinogen, N-nitrosodimethylamine, more commonly …
$1.6 Billion Essure Settlement Announced
On August 20, 2020, Bayer A.G. announced it would pay $1.6 billion to settle Essure claims from women who have been injured by the defective …
New FDA Label Suggested for Breast Implants
On September 29, 2020, the U.S. Food and Drug Administration (FDA) released final labeling recommendations aimed at improving patients’ understanding of the risk associated with …
How Safe is Your Drinking Water?
What is PFAS and Why is it so Dangerous? Simply put, PFAS is class of more than 4,000 different chemicals and turns up in many …
